Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance

Gu,Lei; Deng,Wen‑Sheng; Sun,Xiao‑Fei; Zhou,Hong; Xu,Qing

doi:10.3892/mmr.2016.5392

Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance

Authors:
- Lei Gu
- Wen‑Sheng Deng
- Xiao‑Fei Sun
- Hong Zhou
- Qing Xu
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China, Department of Gastrointestinal Surgery, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China
Published online on: June 10, 2016 https://doi.org/10.3892/mmr.2016.5392
Pages: 1153-1161
Copyright: © Gu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous investigations have suggested that the activation of Th17 cells and/or deficiency of regulatory T cells (Tregs) are involved in the pathogenesis of liver fibrosis. The aim of the present study was to investigate the effect of rapamycin on immune responses in a carbon tetrachloride (CCl4)-induced murine liver fibrosis model. Liver fibrosis was induced by intraperitoneal administration with CCl4. Following injection of CCl4, the mice were treated intraperitoneally with rapamycin (1.25 mg/kg/day) for 8 weeks. Hematoxylin and eosin staining and Masson's trichrome staining were used for histological examination. The protein levels of forkhead/winged helix transcription factor P3, retinoic-acid-related orphan receptor (ROR)‑γt in liver tissue were determined by western blotting, the frequency of Th17 and Treg cells in the liver was evaluated by flow cytometry, and a suppression assay was measured by incorporating [3H]‑thymidine. In addition, to explore the effect of Tregs expanded with rapamycin on hepatic stellate cells (HSC), HSCs were co‑cultured with Tregs from rapamycin or phosphate‑buffered saline‑treated mice. It was found that rapamycin treatment led to a significant reduction in the number of Th17 cells and in the expression levels of ROR‑γt in the liver tissues. Simultaneously, the results of the present study showed a significant increase in the frequency of Tregs and a marked enhancement in the expression of forkhead/winged helix transcription factor P3 in the rapamycin‑treated mice. Furthermore, the Tregs in rapamycin‑treated mice had significantly higher suppressive effects, compared with the cells from mice treated with phospphate‑buffered saline. Consequently, rapamycin treatment prevented the development of CCl4-induced hepatic fibrosis, which was shown by its histological appearances. These results suggested that the immunosuppressive effect of rapamycin on liver fibrosis was associated with the suppression of hepatic fibrogenesis and regulation of the Th17/Treg cell balance.

View Figures

View References

1	Racanelli V and Rehermann B: The liver as an immunological organ. Hepatology. 43(2 Suppl 1): S54–S62. 2006. View Article : Google Scholar : PubMed/NCBI
2	Crispe IN: The liver as a lymphoid organ. Annu Rev Immunol. 27:147–163. 2009. View Article : Google Scholar : PubMed/NCBI
3	Lan RY, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W, Moritoki Y, Ansari AA, Kemper C, Price J, et al: Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun. 32:43–51. 2009. View Article : Google Scholar
4	Wang L, Chen S and Xu K: IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int J Mol Med. 27:385–392. 2011.PubMed/NCBI
5	Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS and Jia JH: Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 19:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
6	Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR and Vignali DA: The development and function of regulatory T cells. Cell Mol Life Sci. 66:2603–2622. 2009. View Article : Google Scholar : PubMed/NCBI
7	Sakaguchi S, Yamaguchi T, Nomura T and Ono M: Regulatory T cells and immune tolerance. Cell. 133:775–787. 2008. View Article : Google Scholar : PubMed/NCBI
8	Fenoglio D, Bernuzzi F, Battaglia F, Parodi A, Kalli F, Negrini S, De Palma R, Invernizzi P and Filaci G: Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev. 12:300–304. 2012. View Article : Google Scholar : PubMed/NCBI
9	Li J, Qiu SJ, She WM, Wang FP, Gao H, Li L, Tu CT, Wang JY, Shen XZ and Jiang W: Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One. 7:e393072012. View Article : Google Scholar : PubMed/NCBI
10	Yasumi Y, Takikawa Y, Endo R and Suzuki K: Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res. 37:248–254. 2007. View Article : Google Scholar : PubMed/NCBI
11	Sun XF, Gu L, Deng WS and Xu Q: Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice. World J Gastroenterol. 20:2062–2070. 2014. View Article : Google Scholar : PubMed/NCBI
12	Shin HJ, Baker J, Leveson-Gower DB, Smith AT, Sega EI and Negrin RS: Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood. 118:2342–2350. 2011. View Article : Google Scholar : PubMed/NCBI
13	Kopf H, de la Rosa GM, Howard OM and Chen X: Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol. 7:1819–1824. 2007. View Article : Google Scholar : PubMed/NCBI
14	Yin H, Li X, Zhang B, Liu T, Yuan B, Ni Q, Hu S and Gu H: Sirolimus ameliorates inflammatory responses by switching the Treg/Th17 profile in murine colitis. Immunology. 139:494–502. 2013. View Article : Google Scholar : PubMed/NCBI
15	Hennig M, Bauer D, Wasmuth S, Busch M, Walscheid K, Thanos S and Heiligenhaus A: Everolimus improves experimental autoimmune uveoretinitis. Exp Eye Res. 105:43–52. 2012. View Article : Google Scholar : PubMed/NCBI
16	Battaglia M, Stabilini A and Roncarolo MG: Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood. 105:4743–4748. 2005. View Article : Google Scholar : PubMed/NCBI
17	Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C and Zhao Y: The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Transpl Immunol. 17:153–161. 2007. View Article : Google Scholar : PubMed/NCBI
18	Ogino H, Nakamura K, Ihara E, Akiho H and Takayanagi R: CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci. 56:376–386. 2011. View Article : Google Scholar
19	Copple BL, Bai S, Burgoon LD and Moon JO: Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis. Liver Int. 31:230–244. 2011. View Article : Google Scholar
20	Chen CH, Kuo LM, Chang Y, Wu W, Goldbach C, Ross MA, Stolz DB, Chen L, Fung JJ, Lu L and Qian S: In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology. 44:1171–1181. 2006. View Article : Google Scholar : PubMed/NCBI
21	Friedman SL: Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 7:425–436. 2010. View Article : Google Scholar : PubMed/NCBI
22	Mack DG, Falta MT, McKee AS, Martin AK, Simonian PL, Crawford F, Gordon T, Mercer RR, Hoover MD, Marrack P, et al: Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease. Proc Natl Acad Sci USA. 111:8553–8558. 2014. View Article : Google Scholar : PubMed/NCBI
23	Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A and Barry S: Foxp3+ regulatory T cells, Th17 effector cells and cytokine environment in inflammatory bowel disease. J Clin Immunol. 30:80–89. 2010. View Article : Google Scholar
24	Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J and Kang I: Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther. 12:R532010. View Article : Google Scholar : PubMed/NCBI
25	Lohr J, Knoechel B, Wang JJ, Villarino AV and Abbas AK: Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med. 203:2785–2791. 2006. View Article : Google Scholar : PubMed/NCBI
26	Rong G, Zhou Y, Xiong Y, Zhou L, Geng H, Jiang T, Zhu Y, Lu H, Zhang S, Wang P, et al: Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: The serum cytokine profile and peripheral cell population. Clin Exp Immunol. 156:217–225. 2009. View Article : Google Scholar : PubMed/NCBI
27	Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS and Gao B: Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology. 56:1150–1159. 2012. View Article : Google Scholar : PubMed/NCBI
28	Fontenot JD, Gavin MA and Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 4:330–336. 2003. View Article : Google Scholar : PubMed/NCBI
29	Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ and Littman DR: The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121–1133. 2006. View Article : Google Scholar : PubMed/NCBI
30	Yin H, Li X, Zhang B, Liu T, Yuan B, Ni Q, Hu S and Gu H: Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. Immunology. 139:494–502. 2013. View Article : Google Scholar : PubMed/NCBI
31	Viglietta V, Baecher-Allan C, Weiner HL and Hafler DA: Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 199:971–979. 2004. View Article : Google Scholar : PubMed/NCBI
32	Lawson JM, Tremble J, Dayan C, Beyan H, Leslie RD, Peakman M and Tree TI: Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin Exp Immunol. 154:353–359. 2008. View Article : Google Scholar : PubMed/NCBI
33	Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton JR Jr, Tester IA, Wang CC, Culbertson N, Vandenbark AA and Rosen HR: Functional suppression by FoxP3+CD4+CD25 (high) regulatory T cells during acute hepatitis C virus infection. J Infect Dis. 197:46–57. 2008. View Article : Google Scholar : PubMed/NCBI
34	Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T and Roncarolo MG: Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol. 177:8338–8347. 2006. View Article : Google Scholar : PubMed/NCBI
35	Tresoldi E, Dell'Albani I, Stabilini A, Jofra T, Valle A, Gagliani N, Bondanza A, Roncarolo MG and Battaglia M: Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells. Haematologica. 96:1357–1365. 2011. View Article : Google Scholar : PubMed/NCBI
36	Saxena A, Dobaczewski M, Rai V, Haque Z, Chen W, Li N and Frangogiannis NG: Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol. 307:H1233–H1242. 2014. View Article : Google Scholar : PubMed/NCBI
37	Huang GC, Zhang JS and Tang QQ: Involvement of C/EBP-alpha gene in in vitro activation of rat hepatic stellate cells. Biochem Biophys Res Commun. 324:1309–1318. 2004. View Article : Google Scholar : PubMed/NCBI